Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8679304 | Thrombosis Research | 2018 | 6 Pages |
Abstract
In this high-risk antithrombin-deficient population, both subjects with low and normal plasma β-antithrombin activity had high risks of first and recurrent VTE. This puts the importance of β-antithrombin into question. Long-term anticoagulation is warranted in antithrombin-deficient VTE patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Frederik Nanne Croles, René Mulder, André B. Mulder, Michaël V. Lukens, Karina Meijer,